Dear WP2, thank you for reminding us:) Please find the news from WP5 below.
WP5 Newsletter April 2019
Since the meeting in Copenhagen in September 2018, WP5 members have made risk assessments of current donor eligibility criteria as well as proposed new ones, identified as part of the first WP5 deliverables (described in the first newsletter). The results are now being comprised into a scientific paper and a report.
Based on this work, the first draft of new guiding principles and guidelines for donor selection was commenced in the early spring 2019. The first draft of guidelines for the selection of donors of whole blood was discussed in a workshop in Amsterdam together with represents from WP3, WP5, WP6 and WP7. Subgroups working with plasma and cells and ART will meet in May to finalize their first draft. The results will be discussed in a teleconference at the end of May in order to complete the work on time by the end of June.
Alongside this work, WP5 have had two abstracts accepted for the 29th regional congress of the International Society for Blood Transfusion (ISBT) in Basel in June 2019 with the titles “A COMPARISON BETWEEN DIRECTIVE 2004/33/EC AND AN EVALUATION BY EXPERTS IN THE TRANSPOSE PROJECT IDENTIFIES INCONGRUENCE IN WHOLE BLOOD DONOR SELECTION CRITERIA” and LARGE DIFFERENCES IN THE REPORTING OF ADVERSE REACTIONS IN BLOOD AND PLASMA DONATION WITHIN THE EUROPEAN UNION – RESULTS FROM THE TRANSPOSE PROJECT.